Main Article Content
insulin; adipocyte fatty acid-binding protein; serum uric acid; type 2 diabetes mellitus; abdominal obesity
Objective: To study the correlations between insulin function and levels of adipocyte fatty acid-binding protein (A-FABP) and serum uric acid (SUA) in newly diagnosed type 2 diabetes mellitus (T2DM) patients with abdominal obesity. Methods: A total of 218 eligible patients were divided into abdominal obesity group (n=98) and non-abdominal obesity group (n=120) according to waist circumference. Their basic data, laboratory indices, levels of A-FABP and SUA, insulin resistance (IR) index [homeostasis model assessment of IR (HOMA-IR)] and insulin secretion index (HOMA-β) were compared. The correlations of HOMA-IR with A-FABP, SUA and HOMA-β were analyzed by Pearson’s test. The risk factors for IR were explored by logistic regression analysis. Results: Body mass index (BMI), waist circumference, waist-to-hip ratio, diastolic blood pressure and systolic blood pressure significantly increased in abdominal obesity group compared with those in non-abdominal obesity group (P<0.05). Compared with non-abdominal obesity group, very low-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglyceride (TG), total cholesterol, aspartate aminotransferase, alanine aminotransferase and fasting serum insulin significantly increased, while high-density lipoprotein cholesterol decreased (P<0.05) in abdominal obesity group. HOMA-IR, HOMA-β and levels of A-FABP and SUA were significantly higher in abdominal obesity group than those in non-abdominal obesity group (P<0.05). HOMA-IR was significantly positively correlated with A-FABP, SUA and HOMA-β (P<0.0001). BMI, TG, waist circumference, A-FABP and SUA were risk factors for IR (P<0.05). Conclusion: A-FABP and SUA levels significantly increase in newly diagnosed T2DM patients with abdominal obesity, being positively correlated with IR. They are risk factors for IR. Reducing fat and weight and controlling the levels of A-FABP and SUA may be able to relieve IR and to prevent T2DM complicated with abdominal obesity.
2. Tangvarasittichai S, Pongthaisong S, Tangvarasittichai O. Tumor Necrosis Factor-Α, Interleukin-6, C-Reactive Protein Levels and Insulin Resistance Associated with Type 2 Diabetes in Abdominal Obesity Women. Indian J Clin Biochem 2016; 31: 68-74.
3. Li C, He JZ, Zhou XD, Xu X. Berberine regulates type 2 diabetes mellitus related with insulin resistance. Zhongguo Zhong Yao Za Zhi 2017; 42: 2254-60.
4. Mudumbi JB, Ntwampe SK, Mekuto L, Matsha T, Itoba-Tombo EF. The role of pollutants in Type 2 Diabetes Mellitus (T2DM) and their prospective impact on phytomedicinal treatment strategies. Environ Monit Assess 2018; 190: 262.
5. Ha KN, Xia Y, Tran Y, Veglia G, Bernlohr DA. Investigating the Conformational Transitions of Human Adipocyte Fatty Acid Binding Protein Upon Binding Leukotriene B4 by Solution-State NMR Spectroscopy. Biophys J 2018; 114: 26a.
6. Bauer F, Pagonas N, Seibert FS, et al. Serum Uric Acid and Arterial Function After Renal Transplantation. Ann Transplant 2017; 22: 431-9.
7. Akter S, Goto A, Mizoue T. Smoking and the risk of type 2 diabetes in Japan: a systematic review and meta-analysis. J Epidemiol 2017; 27: 553-61.
8. Jun-Ren ZH, Run-Lin GA, Shui-Ping ZH, Guo-Ping LU, Dong ZH, Jian-Jun LI. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol 2018; 15: 1-29.
9. Fang F, Zhan YF, Zhuo YY, Yin DZ, Li KA, Wang YF. Brain atrophy in middle-aged subjects with Type 2 diabetes mellitus, with and without microvascular complications. J Diabetes 2018; 10: 625-32.
10. Scott EM, Carpenter JS, Iorfino F, et al. What is the prevalence, and what are the clinical correlates, of insulin resistance in young people presenting for mental health care? A cross-sectional study. BMJ Open 2019; 9: e025674.
11. Zeng H, Luo M, Li Z, et al. Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis. BMJ Open 2019; 9: e029426.
12. Zheng S, Shi S, Ren X, et al. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med 2016; 14: 260.
13. Ahmad N, Adam SI, Nawi AM, Hassan MR, Ghazi HF. Abdominal obesity indicators: waist circumference or waist-to-hip ratio in Malaysian adults population. Int J Prevent Med 2016; 7: 82.
14. Hikasa S, Shimabukuro S, Hideta K, et al. Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study. J Pharm Health Care Sci 2019; 5: 12.
15. Lambert EA, Hachem M, Hemmes R, et al. Serum uric acid and the relationship with subclinical organ damage in adults. J Hypertens 2017; 35: 745-52.
16. Wang YB, Li XF, Chen R, Shen JH, Zhang YH. Association between serum adipocyte fatty acid binding protein level and insulin resistance in patients with OSAS. Zhonghua Yi Xue Za Zhi 2017; 97: 3779-82.
17. Qiu QY, Zhang BL, Zhang MZ, et al. Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of Inner Mongolians in China. Biomed Environ Sci 2018; 31: 300-5.